- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03434067
The Application of Rapid PTH Test Paper in Operation of Hyperparathyroidism
September 17, 2018 updated by: Bo Wang,MD
The half-life of the parathyroid hormone is about 4min, blood pth test is use in operation to confirm that parathyroid tumor is removed.
but the blood pth test is time consuming and unpractical in most of hospital.
this study will compare the application of rapid PTH test paper in operation of hyperparathyroidism.PTH test were measured in operation in different way. it will test at the time of preoperation, 15 minutes after surgery, 1 hour after surgery and 24 hours after surgery.
thus evaluate the reliability and accuracy of PTH test paper in evaluating the Miami principles with the linear relation of blood PTH and the PTH test paper method.
Study Overview
Status
Unknown
Conditions
Detailed Description
Primary hyperparathyroidism is a clinically common disease.
At present, the gold standard for determining whether the operation is successful is based on the Miami principle.
That means The PTH hormone decreased to 30% of the baseline level after 15min after the tumor was removed.
However, due to the differences in PTH monitoring conditions in various hospitals, many hospitals cannot perform rapid PTH monitoring in the operation.
Therefore many doctors choose rapid freezing pathology to confirm the lesion.,
This also led to the inability to evaluate PTH in the presence of multiple lesions,and resulting in the need for reoperations.
Study Type
Observational
Enrollment (Anticipated)
90
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fujian
-
Fuzhou, Fujian, China, 350001
- Recruiting
- Wen-xin ZHAO
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
We use the characteristics of short half-life of the parathyroid hormone and try to evaluate it by PTH strip semi-quantitative method.
PTH, blood calcium and PTH test were measured at pre-operation, 15 minutes after surgery, 1 hour after surgery and 24 hours after surgery.
To evaluate the reliability and accuracy of PTH strip in evaluating the Miami principles with the linear relation of blood PTH and the test paper method.
Description
Inclusion Criteria:
- Primary hyperthyroidism.
- Secondary hyperthyroidism
- Unilateral thyroidectomy.
- Total thyroidectomy and bilateral central compartment dissection
Exclusion Criteria:
- age Older than 70 or younger than 18.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Primary hyperthyroidism
Patients diagnosed with primary hyperparathyroidism are prepared for parathyroid surgery.
PTH test paper is used addtional at the time point according to Miami principle
|
|
Secondary hyperthyroidism
Patients diagnosed with Secondary hyperthyroidism are prepared for parathyroid surgery.
PTH test paper is used addtional at the time point according to Miami principle
|
|
Unilateral thyroidectomy
Patients diagnosed with unilateral thyroid benign tumor were prepared for unilateral thyroidectomy.
PTH test paper is used addtional at postoperation
|
|
thyroidectomy and bilateral CCD
Patients diagnosed with bilateral thyroid carcinoma were prepared to undergo total thyroidectomy and bilateral central clearing.PTH test paper is used addtional at postoperation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum PTH
Time Frame: 0 minutes, 15 minutes, 1 hour and 24 hours post operation
|
Routine serum PTH test, using immunoluminescence.
|
0 minutes, 15 minutes, 1 hour and 24 hours post operation
|
|
Serum calcium
Time Frame: 0 minutes, 15 minutes, 1 hour and 24 hours post operation
|
Routine serum electrolyte detection.
|
0 minutes, 15 minutes, 1 hour and 24 hours post operation
|
|
PTH test paper
Time Frame: 0 minutes, 15 minutes, 1 hour and 24 hours post operation
|
PTH test paper test for blood
|
0 minutes, 15 minutes, 1 hour and 24 hours post operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: wen-xin zhao, md, Fujian Medical University Union Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2018
Primary Completion (Actual)
June 30, 2018
Study Completion (Anticipated)
December 30, 2018
Study Registration Dates
First Submitted
January 27, 2018
First Submitted That Met QC Criteria
February 8, 2018
First Posted (Actual)
February 15, 2018
Study Record Updates
Last Update Posted (Actual)
September 18, 2018
Last Update Submitted That Met QC Criteria
September 17, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PTH test paper
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperthyroidism
-
Centre Hospitalier Princesse GraceCompleted
-
Zhang BoActive, not recruitingHyperthyroidism/ThyrotoxicosisChina
-
Chinese PLA General HospitalRecruitingEfficacy and Safety | Hyperthyroidism/Thyrotoxicosis | Complication Rate | Cure RateChina
-
Dong Jun LimRecruitingHyperthyroidism/ThyrotoxicosisKorea, Republic of
-
Universiti Kebangsaan Malaysia Medical CentreCompletedHyperthyroidism/ThyrotoxicosisMalaysia
-
Medical University of WarsawInstitute of Cardiology, Warsaw, PolandCompletedHyperthyroidism/Thyrotoxicosis | Hyperthyroidism; Goiter | Iodine Induced Thyrotoxicosis | Contrast Media Adverse Reaction | Thyrotoxicosis of Other Specified Origin
-
Rijnstate HospitalZonMw: The Netherlands Organisation for Health Research and Development; University... and other collaboratorsTerminatedRadiofrequency Ablation | Thyroid Nodule, Toxic or With Hyperthyroidism | Autonomous Thyroid Function | Thyroid Nodule; Hyperthyroidism | Iodine Hyperthyroidism | Iodine Adverse ReactionNetherlands
-
IRCCS Ospedale San RaffaeleIRCCS Azienda Ospedaliero-Universitaria di Bologna; Federico II University; Azienda... and other collaboratorsEnrolling by invitationChildren | Autoimmune HyperthyroidismItaly
-
University of BelgradeUnknownPregnancy Complicated by Hyperthyroidism | Hypothyroidism in PregnancySerbia
-
University of BelgradeCompletedPregnancy Complicated by Hyperthyroidism | Hypothyroidism in PregnancySerbia